Skip to main content

Table 1 Data sets summary

From: Transferring genomics to the clinic: distinguishing Burkitt and diffuse large B cell lymphomas

GEO accession

Group

Samples

Probes

Platform

GSE4732_p1

Dave et al. [30]

54 BL, 249 DLBCL

2745

Custom Affymetrix Lympho-Chip

GSE4732_p2

Dave et al. [30]

33 BL, 66 DLBCL

54,675

Affymetrix HG-U133 plus2.0

GSE4475

Hummel et al. [31]

44 mBL, 48 intermediate, 129 non-mBL

22,283

Affymetrix HG-U133A

GSE10172

Klapper et al. [56]

13 mBL, 9 intermediate, 14 non-mBL

22,283

Affymetrix HG-U133A

GSE26673

Piccaluga et al. [57]

13 eBL, 2 HIV-BL

54,675

Affymetrix HG-U133 plus2.0

GSE17189

Deffenbacher et al. [58]

4 HIV-BL, 13 HIV-DLBCL

54,675

Affymetrix HG-U133 plus2.0

 

HMDS

41 BL, 206 DLBCL clinically diagnosed

24,526

Illumina WG-DASL Version_3

 

HMDS

70 BL, 169 DLBCL clinically diagnosed

29,377

Illumina WG-DASL Version_4

  1. eBL endemic BL, GEO Gene Expression Omnibus, HMDS Haematological Malignancy Diagnostic Service, HIV-BL HIV-related Burkitt lymphoma HIV-DLBCL HIV-related diffuse large B cell lymphoma mBL molecular BL defined in corresponding paper